000 | 01733 a2200433 4500 | ||
---|---|---|---|
005 | 20250511200339.0 | ||
264 | 0 | _c19910610 | |
008 | 199106s 0 0 eng d | ||
022 | _a0028-4793 | ||
024 | 7 |
_a10.1056/NEJM199105303242202 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aPoynard, T | |
245 | 0 | 0 |
_aBeta-adrenergic-antagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices. An analysis of data and prognostic factors in 589 patients from four randomized clinical trials. Franco-Italian Multicenter Study Group. _h[electronic resource] |
260 |
_bThe New England journal of medicine _cMay 1991 |
||
300 |
_a1532-8 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article; Meta-Analysis; Multicenter Study; Randomized Controlled Trial | ||
650 | 0 | 4 |
_aAdrenergic beta-Antagonists _xtherapeutic use |
650 | 0 | 4 |
_aAscites _xcomplications |
650 | 0 | 4 |
_aEsophageal and Gastric Varices _xcomplications |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGastrointestinal Hemorrhage _xmortality |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLiver Cirrhosis _xcomplications |
650 | 0 | 4 |
_aLiver Cirrhosis, Alcoholic _xcomplications |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMeta-Analysis as Topic |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aNadolol _xtherapeutic use |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 |
_aPropranolol _xtherapeutic use |
700 | 1 | _aCalès, P | |
700 | 1 | _aPasta, L | |
700 | 1 | _aIdeo, G | |
700 | 1 | _aPascal, J P | |
700 | 1 | _aPagliaro, L | |
700 | 1 | _aLebrec, D | |
773 | 0 |
_tThe New England journal of medicine _gvol. 324 _gno. 22 _gp. 1532-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1056/NEJM199105303242202 _zAvailable from publisher's website |
999 |
_c1680518 _d1680518 |